GPT Healthcare Limited has issued a regulatory disclosure intimating about an upcoming Board of Directors meeting. The meeting is scheduled to be held on Thursday, November 5, 2026.
The Board will consider and approve the following agenda items:
- The Unaudited Financial Results along with the Limited Review Report of the Statutory Auditors for the company for the 2nd quarter and half year ended on September 30, 2026.
- The declaration of an interim dividend for FY 2026-27 on the equity share capital of the company, if any.
The disclosure references compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regarding market compliance, the Trading Window for trading in the company's securities will continue to remain closed until November 7, 2026. This closure is in continuation of the company's previous communication dated September 28, 2026, and is in accordance with the company's "Code of Conduct for Prevention of Insider Trading." The trading window will remain closed until the expiry of 48 hours after the unpublished price sensitive information is submitted to the Stock Exchanges.
This notice is also available on the company's website at https://ilshospitals.com/.
The disclosure was signed by Ankur Sharma, Company Secretary and Compliance Officer (Membership Number: A31833), on October 27, 2026, at 15:26:26 IST.